Duncan Williams Asset Management’s ResMed RMD Stock Holding History

Duncan Williams Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$914K	Sell	4,072 -379	-9%	-$94.4K	0.25%	60
2025 Q4	$1.17M	Sell	4,451 -309	-6%	-$79K	0.29%	48
2025 Q3	$1.3M	Buy	4,760 +142	+3%	+$38.8K	0.37%	40
2025 Q2	$1.19M	Buy	4,618 +749	+19%	+$179K	0.38%	44
2025 Q1	$866K	Buy	3,869 +471	+14%	+$110K	0.31%	55
2024 Q4	$777K	Sell	3,398 -5	-0.1%	-$1.2K	0.31%	57
2024 Q3	$831K	Buy	3,403 +159	+5%	+$35.5K	0.46%	43
2024 Q2	$621K	Buy	3,244 +420	+15%	+$85.2K	0.52%	36
2024 Q1	$559K	Buy	+2,824	New	+$517K	0.5%	36

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Duncan Williams Asset Management's RMD Position: Q1 2026 in Review

Duncan Williams Asset Management reduced its ResMed (RMD) stake by 8.5% in Q1 2026, selling an estimated $94.4K and leaving 4,072 shares worth $914K. The position accounts for 0.25% of the portfolio, ranked #60.

Duncan Williams Asset Management first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.3M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Duncan Williams Asset Management held 4,072 shares of ResMed worth $914K as of Q1 2026.
Duncan Williams Asset Management sold 379 ResMed shares in Q1 2026, an estimated $94.4K.
ResMed made up 0.25% of Duncan Williams Asset Management's portfolio in Q1 2026, its #60 holding.
Duncan Williams Asset Management first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Duncan Williams Asset Management's ResMed position peaked at $1.3M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Duncan Williams Asset Management's 13F filing for Q1 2026, filed 5 May 2026.